ELLIPTIC TECHNOLOGY RECRUITMENT LTD
Company number 14762749 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
ELLIPTIC TECHNOLOGY RECRUITMENT LTD - Analysis Report
Company Number: 14762749
Analysis Date: 2025-07-19 12:15 UTC
Financial Health Assessment of Elliptic Technology Recruitment Ltd
(Financial Year Ended 31 March 2024)
1. Financial Health Score: C
Explanation:
The company is a newly incorporated small private limited company with minimal financial history. It shows basic operational activity with positive net current assets and net equity but limited scale and modest cash reserves. The financial condition is stable but fragile, typical of a start-up, warranting close monitoring as it grows.
2. Key Vital Signs
| Metric | Value | Interpretation |
|---|---|---|
| Cash at Bank | £14,165 | Healthy cash reserve relative to liabilities, indicating liquidity is currently sufficient to meet short-term needs. |
| Current Liabilities | £13,433 | Close to cash level; careful management needed to avoid liquidity strain. |
| Net Current Assets | £732 | Positive but very slim working capital; limited buffer for unexpected expenses or growth investment. |
| Net Assets (Equity) | £732 | Positive shareholder funds, indicating the company is solvent with assets exceeding liabilities. |
| Profit for the Year | £21,731 | Shows initial profitability, a positive symptom of business viability. |
| Dividends Paid | £21,000 | Nearly all profits distributed as dividends, which reduces retained earnings and cash reserves. |
| Loan from Director | £7,376 | Interest-free, unsecured loan from director provides additional support but is a liability that must be managed. |
3. Diagnosis: Financial Condition Assessment
Liquidity ("Healthy Cash Flow"): The company holds a reasonable cash balance (£14,165) relative to its short-term liabilities (£13,433), indicating it can currently meet immediate financial obligations without distress. This is a vital sign of financial health in early-stage businesses, ensuring operational continuity.
Working Capital ("Symptom of Stability but Fragility"): The net current assets of £732 reveal a very tight margin between current assets and liabilities. While positive, it leaves little room for error or unexpected costs. This tight working capital is typical in start-ups but signals a need for vigilant cash flow management.
Profitability and Dividend Policy ("Symptom of Reward but Risk"): The company generated a profit of £21,731, a promising sign of operational success in its first year. However, nearly all profits were paid out as dividends (£21,000), which reduces the company’s ability to reinvest earnings for growth or build financial resilience.
Capital Structure ("Symptom of Early-stage Funding"): Share capital is minimal (£1), and there is a director’s loan of £7,376, which acts as informal financing. This reliance on director loans is common but should be formalized and monitored to avoid potential liquidity or governance issues.
Size and Scale ("Symptom of Start-up Phase"): With only one employee (the director), minimal fixed assets, and limited turnover data, the company is in its infancy. This means financial indicators are less predictive than for mature companies and require cautious interpretation.
4. Recommendations: Improving Financial Wellness
Build Working Capital Buffer: Retain a portion of profits rather than distributing most as dividends to strengthen working capital and provide a financial cushion against unforeseen expenses or downturns.
Formalize Director Loan Terms: Document and formalize the director loan agreement to clarify repayment terms and conditions. This improves financial transparency and governance.
Increase Revenue and Scale Gradually: Focus on growing revenues and diversifying client base to enhance profitability and reduce dependency on single sources of funding.
Implement Cash Flow Forecasting: Regularly monitor cash flow projections to avoid liquidity crunches. Plan for seasonal fluctuations and invest in systems to track financial performance accurately.
Consider Additional Capital Injection: If growth requires, explore options for equity investment or bank financing to reduce reliance on director loans and strengthen the balance sheet.
Maintain Compliance and Timely Filings: Ensure ongoing compliance with Companies House filing deadlines to avoid penalties and maintain company credibility.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.